Clinical trials for Lacripep, developed at the UVA School of Medicine, begin in March. The new drug may offer new relief for patients and a new revenue stream for the University.

A nurse practitioner meets with heart-failure patients after they’ve returned to their homes to head off problems and help keep them out of the hospital.

With time being critical in treating strokes, the ability to better assess patients before they reach the hospital could save lives and brain function.

The test, developed by doctors at U.Va. and West Virginia University, gives teens an early warning of future problems, but with plenty of time to change behaviors and lower the risks.